| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 702378 | Null | 0.00295310816022625 | 0.3511948 |
| NSC 704639 | Null | 0.00295310816022625 | 0.12588632 |
| NSC 711739 | Null | 0.00295310816022625 | 0.30924889 |
| NSC 718185 | Null | 0.00295310816022625 | 0.36490477 |
| NSC 743227 | 2-chloro-1-[4-(4-chloro-1-cyclohexyl-2,5-dioxo-2,5-dihydro-1 H-3-pyrrolylamino)phenylcarboxamido]benzene | 0.00295310816022625 | 0.35965512 |
| NSC 745062 | Null | 0.00295310816022625 | 0.36988266 |
| NSC 746035 | 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone | 0.00295310816022625 | 0.22461493 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.00295310816022625 | 0.35790995 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.00295310816022625 | 0.14135172 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.00313644776247642 | 0.41344336 |